
Gemita Injection
Marketer
Fresenius Kabi India Pvt Ltd
Salt Composition
Gemcitabine (1400mg) + Mannitol (36.8ml)
Overview Gemita Injection
Oncaspar injection is a prescription medication indicated for treating cancers of the lung (non-small cell), breast, pancreas, bladder, and ovaries. Its mechanism involves inhibiting cancer cell proliferation and promoting tumor regression. Administration must be overseen by a qualified healthcare provider; self-injection is strictly prohibited. Report any allergies to this medication to your physician immediately. Potential side effects include nausea, vomiting, alopecia, anemia (low red blood cell count), and leukopenia (low white blood cell count). Pre- and/or during-treatment blood tests may be required. Supplementation might be necessary to address medication-induced deficiencies. A diet rich in fruits and vegetables is also recommended. Disclose all other medications, pregnancy status, and existing health conditions to your doctor. This medication is contraindicated during breastfeeding. Alcohol consumption should be avoided. Refrain from driving or operating heavy machinery while undergoing treatment.
Uses of Gemita Injection
Malignant neoplasm
Major Benefits of Gemita Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Gemita Injection:
- Nausea
- Vomiting
- Diarrhea
- Decreased blood cells (red cells, white cells, and platelets)
- Rash
- Increased liver enzymes
- Blood in urine
- Protein in urine
- Breathlessness
How to use Gemita Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Gemita Injection works:
Gemita Injection merges gemcitabine and mannitol. Gemcitabine hinders cancer cell proliferation by disrupting DNA and RNA synthesis, effectively blocking their growth and reproduction. Mannitol, a pharmacologically inactive compound, possesses high osmotic properties, promoting diuresis by drawing fluid into the kidneys. Its additional uses include intraocular pressure reduction and cerebral edema management.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Gemita Injection and alcohol may result in pronounced somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Gemita Injection during pregnancy is contraindicated due to established risks to fetal development. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Gemita Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Gemita Injection might reduce alertness, impair vision, or induce drowsiness and dizziness. Driving should be avoided if these effects manifest.
KidneySAFE IF PRESCRIBED
The use of Gemita Injection in patients with kidney impairment appears safe. Preliminary evidence indicates dose modification may be unnecessary, but physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Gemita Injection's use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Gemita Injection :
NA
Facts to Know About Gemita Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
